Oral famotidine versus placebo in non-hospitalised patients with COVID-19: a randomised, double-blind, data-intense, phase 2 clinical trial
Brennan et al., Gut, doi:10.1136/gutjnl-2022-326952
https://c19early.org/brennan.html